Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Advertisement

Advertisement




Dec
18
Today In Oncology
Community Oncology Report Showcases Barriers to Therapy Access, Staffing, and Clinical Trial Participation
FDA Approves CAR T-Cell Therapy for Relapsed/Refractory Marginal Zone Lymphoma
Addition of Eflornithine to Lomustine in Patients With Recurrent Grade 3 Astrocytoma
Preoperative PAXG vs mFOLFIRINOX in Pancreatic Ductal Adenocarcinoma
Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced NSCLC
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo